Alivus Life

{
  "main_header": {
    "sid": 1003513,
    "name": "Alivus Life",
    "stock_name": "Alivus Life",
    "full_name": "Alivus Life Sciences Ltd",
    "name_url": "stocks-analysis/alivus-life",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,328.30",
    "chg": 6.9,
    "chgp": "0.52%",
    "dir": 1,
    "prev_price": "1,321.40",
    "mcapval": "16,345.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543322,
    "symbol": "ALIVUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE03Q201024",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "19:33 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "90.04 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alivus-life-1003513-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alivus Life Sciences Gains 14.59%: 7 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-gains-1459-7-key-factors-driving-the-weeks-momentum-4143076",
        "imagepath": "",
        "date": "2026-08-08 12:02:29",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>3 Aug:</strong> New 52-week high at Rs.1,223.60</p>\n                    <p><strong>4 Aug:</strong> Intraday high surge to Rs.1,310 and Mojo Score upgrade</p>\n                    <p><strong>5 Aug:</strong> Downgrade to Hold amid valuation concerns</p>\n                    <p><strong>6 Aug:</strong> New 52-week high at Rs.1,361.95</p>\n                    <p><strong>7 Aug:</strong> Week closes at Rs.1,328.30 (+0.52%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,211.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Cl..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Alivus Life Sciences Ltd to 52-Week High of Rs 1361.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-hits-new-52-week-high-at-rs136195-4139993",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_priceRelatedfactors_4139993.png",
        "date": "2026-08-06 10:21:59",
        "description": "With a decisive surge to Rs 1361.95 on 6 Jun 2026, Alivus Life Sciences Ltd has reached a new 52-week and all-time high, marking a 43.4% gain over the past year. This rally stands out amid a broadly positive market backdrop, driven by a confluence of strong technical signals across multiple timeframes."
      },
      {
        "title": "Alivus Life Sciences Downgraded to Hold Amid Valuation Concerns Despite Strong Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-downgraded-to-hold-amid-valuation-concerns-despite-strong-technicals-4137377",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_mojoScore_4137377.png",
        "date": "2026-08-05 08:42:21",
        "description": "Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 4 August 2026. This shift reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate robust technical momentum and solid management efficiency, concerns over its elevated valuation and flat recent financial performance have tempered enthusiasm among analysts."
      },
      {
        "title": "Alivus Life Sciences Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-valuation-shifts-signal-changing-market-sentiment-4136957",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_valuationdot_4136957.png",
        "date": "2026-08-05 08:03:36",
        "description": "Alivus Life Sciences Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, prompting a reassessment of its price attractiveness amid a strong rally. This change reflects evolving investor sentiment in the Pharmaceuticals & Biotechnology sector, with implications for both current and prospective shareholders."
      },
      {
        "title": "Alivus Life Sciences Ltd Surges 7.42% to Day's High of Rs 1310 — Outperforms Sector by 7.82 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-hits-intraday-high-with-742-surge-on-4-aug-2026-4135591",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_priceRelatedfactors_4135591.png",
        "date": "2026-08-04 11:02:06",
        "description": "The Sensex edged up a mere 0.01% on 04 Aug 2026, while Alivus Life Sciences Ltd surged 7.42%, hitting an intraday high of Rs 1310. This 7.82-percentage-point outperformance over its Pharmaceuticals &amp; Biotechnology sector peers signals a distinctly stock-specific rally rather than a broad market lift."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Alivus Life Sciences Ltd to 52-Week High of Rs 1229.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-hits-new-52-week-high-at-rs122995-4135204",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_priceRelatedfactors_4135204.png",
        "date": "2026-08-04 09:50:18",
        "description": "With a decisive breakthrough to Rs 1229.95 on 4 Aug 2026, Alivus Life Sciences Ltd has reached a fresh 52-week high, extending its impressive 24.76% return over the past year. This milestone is underpinned by a strong alignment of technical indicators and sustained price momentum, even as the broader Sensex trades near its own recent peaks."
      },
      {
        "title": "Alivus Life Sciences Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-sees-bullish-momentum-shift-amid-strong-technical-signals-4135378",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_technicaldot_4135378.png",
        "date": "2026-08-04 08:10:20",
        "description": "Alivus Life Sciences Ltd has demonstrated a notable shift in technical momentum, upgrading its market stance from mildly bullish to bullish. This change is underpinned by strong signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting an increasingly positive outlook for this small-cap pharmaceutical and biotechnology stock."
      },
      {
        "title": "Why is Alivus Life Sciences Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-alivus-life-sciences-ltd-fallingrising-4134245",
        "imagepath": "",
        "date": "2026-08-04 01:27:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Price Performance and Market Outperformance</strong></p>\n<p>Alivus Life Sciences has demonstrated impressive returns relative to the broader market benchmarks. Over the past week, the stock surged by 7.19%, significantly outpacing the Sensex’s 2.35% gain. This trend extends over longer periods, with the company delivering a 32.11% return year-to-date compared to the Sensex’s decline of 7.72%. Over one year, the stock has appreciated by 21.03%, while the benchmark index fell by 2.43%. Even more striking is the three-year performance, where Alivus Life Sciences has nearly doubled investors’ money with a 92.59% gain, far exceeding the Sensex’s 20.54% rise.</p>\n<p>Today’s trading session further reinforced this positive trajectory, with the stock outperforming its sector by 4.17% and regi..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Alivus Life Sciences Ltd to 52-Week High of Rs 1223.6",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-hits-new-52-week-high-at-rs12236-4133273",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_priceRelatedfactors_4133273.png",
        "date": "2026-08-03 09:53:32",
        "description": "With a decisive surge to Rs 1223.6 on 3 Aug 2026, Alivus Life Sciences Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces its sector and the broader market."
      }
    ],
    "total": 329,
    "sid": "1003513",
    "stock_news_url": "https://www.marketsmojo.com/news/alivus-life-sciences-1003513"
  },
  "announcements": [
    {
      "caption": " Intimation Of Record Date For Dividend",
      "datetime": "06-Aug-2026",
      "details": "Intimation of Record date for Dividend.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of 15Th Annual General Meeting And Record Date.",
      "datetime": "06-Aug-2026",
      "details": "Intimation of 15th Annual General Meeting and Record date.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Aug-2026",
      "details": "Newspaper Advertisement for 15th Annual General Meeting (AGM)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alivus Life Sciences Gains 14.59%: 7 Key Factors Driving the Week’s Momentum

2026-08-08 12:02:29

Key Events This Week

3 Aug: New 52-week high at Rs.1,223.60

4 Aug: Intraday high surge to Rs.1,310 and Mojo Score upgrade

5 Aug: Downgrade to Hold amid valuation concerns

6 Aug: New 52-week high at Rs.1,361.95

7 Aug: Week closes at Rs.1,328.30 (+0.52%)

Week Open

Rs.1,211.80

Week Cl...

Read full news article

Broad-Based Technical Strength Lifts Alivus Life Sciences Ltd to 52-Week High of Rs 1361.95

2026-08-06 10:21:59

With a decisive surge to Rs 1361.95 on 6 Jun 2026, Alivus Life Sciences Ltd has reached a new 52-week and all-time high, marking a 43.4% gain over the past year. This rally stands out amid a broadly positive market backdrop, driven by a confluence of strong technical signals across multiple timeframes.

Read full news article

Alivus Life Sciences Downgraded to Hold Amid Valuation Concerns Despite Strong Technicals

2026-08-05 08:42:21

Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 4 August 2026. This shift reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate robust technical momentum and solid management efficiency, concerns over its elevated valuation and flat recent financial performance have tempered enthusiasm among analysts.

Read full news article

Alivus Life Sciences Ltd Valuation Shifts Signal Changing Market Sentiment

2026-08-05 08:03:36

Alivus Life Sciences Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, prompting a reassessment of its price attractiveness amid a strong rally. This change reflects evolving investor sentiment in the Pharmaceuticals & Biotechnology sector, with implications for both current and prospective shareholders.

Read full news article

Alivus Life Sciences Ltd Surges 7.42% to Day's High of Rs 1310 — Outperforms Sector by 7.82 Percentage Points

2026-08-04 11:02:06

The Sensex edged up a mere 0.01% on 04 Aug 2026, while Alivus Life Sciences Ltd surged 7.42%, hitting an intraday high of Rs 1310. This 7.82-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a broad market lift.

Read full news article

Broad-Based Technical Strength Lifts Alivus Life Sciences Ltd to 52-Week High of Rs 1229.95

2026-08-04 09:50:18

With a decisive breakthrough to Rs 1229.95 on 4 Aug 2026, Alivus Life Sciences Ltd has reached a fresh 52-week high, extending its impressive 24.76% return over the past year. This milestone is underpinned by a strong alignment of technical indicators and sustained price momentum, even as the broader Sensex trades near its own recent peaks.

Read full news article

Alivus Life Sciences Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals

2026-08-04 08:10:20

Alivus Life Sciences Ltd has demonstrated a notable shift in technical momentum, upgrading its market stance from mildly bullish to bullish. This change is underpinned by strong signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting an increasingly positive outlook for this small-cap pharmaceutical and biotechnology stock.

Read full news article

Why is Alivus Life Sciences Ltd falling/rising?

2026-08-04 01:27:03

Strong Price Performance and Market Outperformance

Alivus Life Sciences has demonstrated impressive returns relative to the broader market benchmarks. Over the past week, the stock surged by 7.19%, significantly outpacing the Sensex’s 2.35% gain. This trend extends over longer periods, with the company delivering a 32.11% return year-to-date compared to the Sensex’s decline of 7.72%. Over one year, the stock has appreciated by 21.03%, while the benchmark index fell by 2.43%. Even more striking is the three-year performance, where Alivus Life Sciences has nearly doubled investors’ money with a 92.59% gain, far exceeding the Sensex’s 20.54% rise.

Today’s trading session further reinforced this positive trajectory, with the stock outperforming its sector by 4.17% and regi...

Read full news article

Broad-Based Technical Strength Lifts Alivus Life Sciences Ltd to 52-Week High of Rs 1223.6

2026-08-03 09:53:32

With a decisive surge to Rs 1223.6 on 3 Aug 2026, Alivus Life Sciences Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces its sector and the broader market.

Read full news article

View All News